Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 464 Lymphoid 396 Myeloid 232 Plasma cell 140 Dermatologic 107 Classical hematology 86 Sarcoma 56 Genitourinary 34 Gastrointestinal 23 Gynecologic 20 CNS 19 Breast 18 Head & Neck 17 Thoracic 11 Other neoplasm 8 Other solid neoplasm 7 Tumor-Agnostic 4 NET 2 Endocrine 2 Other 1

Conditions

Mucositis 1 Leukemia 1

Interventions

Exercise 27 Metformin 24 Methods 14 Radiotherapy 13 Early Intervention, Educational 13 Educational Status 12 Counseling 12 Surveys and Questionnaires 10 Standard of Care 10 Nutrition Assessment 9 Resistance Training 8 Diet Therapy 8 Cisplatin 8 naloxegol 7 Tirzepatide 7 Diet 7 alvimopan 6 Psychiatric Rehabilitation 6 Fibroblast Growth Factor 7 6 Caloric Restriction 6 Radiation 5 Low-Level Light Therapy 5 Liraglutide 5 Injections 5 Exenatide 5 Dexamethasone 5 Cryotherapy 5 semaglutide 4 angiotensin I (1-7) 4 Vitamin D 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × fludarabine phosphate × Other × Clear all

NCT01085617 2025-03-30

UKALL14

University College, London

OtherOther hematologic neoplasm

Leukemia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡